Jump to content
World's Largest Herpes Support Group
  • ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.

  • Donate

    If Honeycomb has helped you, please help us by making a donation so we can provide you with even better features and services.

  • The Hive is Thriving!

    • Total Topics
    • Total Posts
  • 0_unsure-if-it-is-herpes.png

    Nervous about dating with herpes? Skip "the talk" and browse profiles here.

  • Posts

    • Muscha
      ComevOn pal.  You can do better than that.  Give me something to work with here.  Dont hate cause I play the game better than you.
    • null
    • Muscha
    • null
      Holy shit shut the fuck up already you dumb fucking drone. Everyone else left the thread and you're still spewing you're contradictory bullshit you fucking infant. You're a Nazi, we get it, and you should be banned. And if you're gonna keep going - learn to rub the two braincells you have left together and don't resort to bottom feeder racist insults like "hurrr you fuck goats cuz , durr you said some ting M-muslimmm" you smooth-brained frothing idiot.
    • TCBH
      Looks like AiCuris is gearing up to start Phase 3 next year.  Side note:  This was supposed to be fast tracked by the FDA.  This doesn't seem like it has been fast tracked to me. Poor AiCuris has been working on this for years and because of some toxicity in primates at 90 times the normal dosage, it's been an uphill battle to get this approved.  It looks like there's light at the end of the tunnel but at what price.  I mean price as in what will it cost?  If a company is hindered and has to spend untold amounts of money to get a product to market, who pays for it?  Usually the patients.....sorry for the sad spin but it's just frustrating to see this kind of governance. Silver lining, maybe will have Pritelivir as an option by 2021.   http://www.aicuris.com/127n143AiCuris-Provides-Corporate-Update.htm Internal development program Pritelivir – Phase 2 trial ongoing, AiCuris to conduct Phase 3 pivotal trial in Acyclovir resistant HSV infections in immunocompromised patients Pritelivir (AIC316) is a highly potent inhibitor of herpes simplex virus (HSV) replication and is active against both HSV types 1 and 2. Pritelivir belongs to a new chemical class and acts via a novel mechanism of action. In contrast to currently used nucleoside analogues, Pritelivir does not require activation by viral enzymes and can thus protect uninfected cells. Pritelivir also retains activity against viruses which have become resistant to current standard of care drugs. Pritelivir has demonstrated superior efficacy in a Phase 2 trial compared to the standard treatment, valaciclovir, and is currently in another Phase 2 trial in immunocompromised patients with acyclovir-resistant infection. AiCuris plans to initiate a pivotal Phase 3 trial with Pritelivir in HSV infections in 2020.
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.